Addex Therapeutics Ltd (ADXN.SW)

Switzerland · Healthcare · CHF

Key financials

ROE: -93.16%; 2025 (actual)
ROA: -78.96%; 2025 (actual)
Gross Margin: 100%; 2025 (actual)
Net Margin: -
Total Assets: CHF 6,364.27K; 2025 (actual)
Net Income: -CHF 6,728.25K; 2025 (actual)
Valuation: CHF 11,650.19K; 2025 (actual)
Stock Price: CHF 0.06; 2025 (actual)

Amounts in CHF (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for Addex Therapeutics Ltd? It covers the balance sheet, income statement and Equlion model projections.